BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/15/2015 10:11:00 AM | Browse: 295 | Download: 428
Publication Name World Journal of Methodology
Manuscript ID 15820
Country/Territory Australia
Received
2014-12-10 16:58
Peer-Review Started
2014-12-12 08:24
To Make the First Decision
2015-01-08 14:08
Return for Revision
2015-01-17 13:20
Revised
2015-09-07 00:00
Second Decision
2015-10-10 19:32
Accepted by Journal Editor-in-Chief
2015-10-11 01:11
Accepted by Company Editor-in-Chief
2015-10-27 18:14
Articles in Press
2015-10-27 18:14
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2015-12-03 13:13
Publish the Manuscript Online
2015-12-15 10:10
ISSN 2222-0682 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Methodology
Manuscript Type Editorial
Article Title Toward phase 4 trials in heart failure: A social and corporate responsibility of the medical profession
Manuscript Source Invited Manuscript
All Author List Pupalan Iyngkaran and Glen S Beneby
Funding Agency and Grant Number
Corresponding author Dr. Pupalan Iyngkaran, MBBS, FRACP, Consultant Cardiologist, NT Medical School, Research Fellow and Senior Lecturer Flinders University, PO Box 41326, Casuarina, Darwin NT 0815, Australia. gbeneby@batelnet.bs
Keywords Clinical trial; Corporate responsibility; Health system; Congestive heart failure; Phase 4
Core Tip This commentary brings needed and timely attention to phase 4 or postmarketing surveillance. Only a handful of congestive heart failure (CHF) therapies have actually been studied in the community after the randomized controlled trial. In this millennium it is important we not only innovate and support trials of new therapies, but also ensure the therapies we are already using are effective for all patients. As drug discovery and randomised controlled trial evidence is often done by private sector pharmaceuticals, we thus feel the need to bring attention on treating health care teams to regularly generate efficacy and effectiveness data for the CHF treatments they prescribe.
Publish Date 2015-12-15 10:10
Citation Iyngkaran P, Beneby GS. Toward phase 4 trials in heart failure: A social and corporate responsibility of the medical profession. World J Methodol 2015; 5(4): 179-184
Url http://www.wjgnet.com/2222-0682/full/v5/i4/179.htm
DOI http://dx.doi.org/10.5662/wjm.v5.i4.179
Full Article (PDF) WJM-5-179.pdf
Full Article (Word) WJM-5-179.doc
Manuscript File 15820-Review.doc
Answering Reviewers 15820-Answering reviewers.pdf
Audio Core Tip 15820-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 15820-Conflict-of-interest statement.pdf
Copyright License Agreement 15820-Copyright assignment.pdf
Peer-review Report 15820-Peer-review(s).pdf
Journal Editor-in-Chief Review Report 15820-Journal editor-in-chief review report.pdf
Scientific Misconduct Check 15820-Scientific misconduct check.pdf
Scientific Editor Work List 15820-Scientific editor work list.pdf